m+Medelevator.RU
← Поиск публикаций
Ocular immunology and inflammation · 2026

Non-Neoplastic Uveitis Masquerade Syndromes: Insights from a Case Series.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Baharani Abhilasha

Аннотация

PURPOSE: To study the clinical characteristics and implications of non-neoplastic uveitis masquerade syndromes (NNUMS).

METHODS: A retrospective study of 1595 patients referred for evaluation of uveitis at a tertiary referral center in South India between July 2019 and July 2025. The clinical characteristics and outcomes of patients with NNUMS were evaluated.

RESULTS: Eighty eyes of 53 patients (40 males [75.5%], 13 females [24.5%] mean age 40.3 ± 15.7 years) were diagnosed with NNUMS. Forty-four (83%) patients had fundus lesions. Multimodal imaging was crucial in establishing the diagnosis in 46 (86.8%) patients. Retinal vascular diseases (22.6%), inherited retinal diseases (20.8%) and central serous chorioretinopathy (11.3%) were the most common etiological diagnoses. In 13 (24.5%) patients the diagnosis was delayed by more than 100 days. Twenty-seven (50.9%) patients were receiving anti-inflammatory therapy at presentation. The likelihood of unnecessary anti-inflammatory treatment was significantly higher (p < 0.001) in patients with a diagnostic delay >100 days than those without. Thirteen (24.5%) patients had underlying systemic disease, 92% of whom were previously undiagnosed until the ocular diagnosis was made. Retinal vascular involvement was significantly (p < 0.0001) associated with presence of underlying systemic condition.

CONCLUSIONS: NNUMS are a heterogenous group of clinical entities which mimic ocular inflammatory diseases often resulting in misdiagnosis and unnecessary anti-inflammatory treatment. Recognizing the clinical and imaging features of common clinical manifestations is key to accurate diagnosis and reducing visual morbidity.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты